MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2024 International Congress

    Empower-PD: “An Exploratory Investigation of Accelerometer Data on Parkinson’s Patients’ Motor Symptoms and the Correlation with Quality of Life.”

    M. Hansen, B. Sørensen, T. Thomsen, N. Karottki (Copenhagen, Denmark)

    Objective: To describe weekly changes in bradykinesia-score (BKS) measured on objective wearable data and assess the correlation between these changes and Quality of Life (QoL)…
  • 2024 International Congress

    Evaluating the Effect of Myofascial Release on Parkinson’s Related Tremor

    S. Phelps (Cardiff, United Kingdom)

    Objective: Parkinson’s disease (PD) is the second-fastest neurological disorders in the world. Although there is no cure, medicines, surgical treatment, and other therapies can treat…
  • 2024 International Congress

    The First of Its Kind Genetics Cohort: the Black and African American Connections to Parkinson’s Disease (BLAAC PD) Study

    N. Louie, J. Solle, S. Bandrés-Ciga (New York, USA)

    Objective: Recruit and characterize a Black and African American (BAA) cohort to better understand Parkinson’s disease (PD). Background: A significant gap exists in our understanding…
  • 2024 International Congress

    Genetic Modifiers of Age at Onset for Parkinson’s Disease in Chinese Population

    H. Pan, L. Liu, J. Guo, B. Tang, Y. Zhao (Changsha, China)

    Objective: This study aimed to identify novel genetic modifiers of age at onset (AAO) for Parkinson’s disease (PD) including common variants and rare variants using…
  • 2024 International Congress

    Parkinson’s Disease Risk Genotypes at the GPNMB Locus Associate with Extent of Post-mortem Lewy Pathology

    E. Brody, E. Suh, V. van Deerlin, J. Trojanowski, E. Lee, A. Chen-Plotkin (PHILADELPHIA, USA)

    Objective: To determine whether Parkinson’s disease (PD) risk genotypes at the GPNMB locus associate with distribution of Lewy pathology in brain samples from a spectrum…
  • 2024 International Congress

    Association of Impulse Control Disorder with GRIN2B Gene Polymorphisims in Parkinson Disease

    G. Memari, E. Erzurumluoglu, N. Durmaz Celik, S. özkan, S. Artan (Eskisehir, Turkey)

    Objective: The aim of this study was to investigate the effect of GRIN2B gene rs1806201 and rs7301328 polymorphisms on the development of Impulse Control Disorder…
  • 2024 International Congress

    Association of Liver Fibrosis with Motor Deficits in Parkinson’s Disease

    A. Zolin, H. Ooi, H. Sarva (New York, USA)

    Objective: To determine the impact of liver fibrosis on motor symptoms in Parkinson’s disease Background: Parkinson’s disease motor symptoms can vary with systemic illnesses [1,2].…
  • 2024 International Congress

    Maintaining Isometric Contraction in Parkinson’s Disease: Effect of PD-Medication on EMG Amplitude

    B. Afsharipour, F. Roy, M. Schindle, F. Ba, M. Gorassini, T. Sankar (Edmonton, Canada)

    Objective: To quantify muscle activity changes in PD with dopaminergic medication. Background: Parkinson's disease (PD) is characterized by motor symptoms that improve with dopaminergic medication.…
  • 2024 International Congress

    Predictive Accuracy of Baseline DaT-SPECT for Freezing of Gait at 5, 7, and 10-year Follow up in The PPMI Cohort

    J. Li, R. Rajmohan, J. Ruiz Tejeda, N. Phielipp (Irvine, USA)

    Objective: To see if segmentation models of baseline DaT-SPECT striatal binding ratios (SBR) will predict freezing of gait (FoG) in Parkinson’s Disease over a 5,…
  • 2024 International Congress

    Women with Parkinson’s disease: exploring the occurrence of hormone-related symptom fluctuations and associated care

    W. Kapelle, A. Oosterbaan, E. Stuart, H. Bogers, B. Bloem, M. Meinders, B. Post (Nijmegen, Netherlands)

    Objective: To explore the occurrence of hormone-related symptom fluctuations and associated care in women with Parkinson’s disease (PD). Background: Pre- and (peri)menopausal women with PD…
  • « Previous Page
  • 1
  • …
  • 75
  • 76
  • 77
  • 78
  • 79
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley